LNTH
Lantheus Holdings, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
100.94
close · 2026-08-13
value
34
cheaper than peers34
quality
85
stronger fundamentals85
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 5.42× | 47 |
| EV to EBITDA | 16.73× | 44 |
| forward P/E | 16.03× | 39 |
| price to sales | 4.23× | 31 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 25.8% | 87 |
| return on equity | 22.2% | 77 |
| debt to equity | 43.5% | 74 |
| revenue growth | 2.7% | 33 |
4 of 4 measures available
Facts
| market cap | $7B |
| free cash flow | $421.7M |
| employees | 1,193 |
| first trade | 2015-06-25 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-07 |